No Data
CICC: The time is ripe for consumption to flow back home and for attracting overseas spending; the "Four Confidences" are driving a broad-based recovery in the sector.
At this juncture, there should no longer be any preoccupation with the marginal impact of real estate prices or capital market performance on consumption. Strengthening the 'Four Confidences' will help restore consumer confidence and drive an overall recovery in the consumer sector.
Huayuan Securities: The cosmetics sector demonstrated steady performance in Q1 2026, with high-quality domestic brands showcasing strong competitiveness.
In 2025, the year-on-year growth rate of retail sales of cosmetics products by large-scale enterprises in China reached 5.1%, surpassing the overall growth rate of 3.7% for total retail sales of consumer goods in China, with overall performance remaining relatively stable.
Langzi Co., Ltd. (002612): Medical aesthetics and women's apparel maintain robust double-digit growth; focus on the expansion of the medical aesthetics segment and upward profit recovery.
The company's total revenue for Q1 of 26 years was RMB 1.609 billion, representing a year-on-year increase of 11.98%, maintaining double-digit growth; the net profit attributable to shareholders was RMB 0.49 billion, a year-on-year decrease of 49.4%; the non-GAAP net profit was RMB 0.74 billion, a year-on-year increase of 1.65%, excluding non-recurring items.
CSC Financial: Supply optimization is nearing completion; emphasize the revaluation of balance sheets.
The bank believes that during the 15th Five-Year Plan period, consumption will still require attention to niche alpha opportunities. On one hand, the logic of Chinese brands going global and consumption repatriation is becoming increasingly smooth; on the other hand, there are opportunities for balance sheet revaluation.
From 'traffic marketing' to 'diagnostic assistance,' the industry calls for attention to the data security and effectiveness of AI in medical aesthetics | AI Reshapes Healthcare
①Multiple listed and leading medical aesthetics companies stated that the current application of AI in the medical aesthetics sector is primarily concentrated in marketing, content generation, and process management. ②However, while leading institutions are leveraging AI to reduce costs and improve efficiency, small and medium-sized institutions are still in the 'trial' phase. Additionally, data security and effectiveness remain areas for improvement. ③Industry insiders predict that unmanned clinics and medical aesthetics concierge services will emerge in the future, with AI potentially playing a more central role.
Langzi Co., Ltd. (002612): Q1 2026 revenue grew by double digits, and the year-on-year growth rate of non-GAAP net profit turned positive.
The company released its Q1 2026 financial report, with results meeting market expectations. Revenue for Q1 2026 was RMB 1.609 billion, a year-on-year increase of 11.98%; net profit attributable to parent company was RMB 49.3395 million, a year-on-year decrease of 49.40%; non-recurring net profit was RMB 7.4 million.